Plain-English translation of NCT04865939 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Phase 3 โ Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
After surgery to remove cancer from the upper urinary tract (the kidney and ureter), cancer can sometimes come back in the bladder. This trial is testing whether , a chemotherapy medication, can be placed directly into the bladder during your surgery to help prevent this recurrence. The study compares this approach to continuous flushing of the bladder with sterile water, to see which method works better at keeping cancer from returning.
Up to half of patients who have upper tract cancer surgery develop cancer in their bladder afterward. Doctors think tumor cells may shed during surgery and seed the bladder, so this trial is testing whether the medication can reduce this risk better than water irrigation alone.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
During your surgery to remove the upper tract cancer, you will receive one of two bladder treatments: either medication instilled into your bladder to sit for 1โ3 hours, or continuous flushing with sterile water for 1โ3 hours. The treatment is given as part of your surgical procedure, not as a separate visit. You will be followed by your medical team afterward to monitor for any recurrence of cancer and to watch for side effects.
AI-generated summary from trial data ยท Aug 30, 2026 ยท Not medical advice
United States